UCSF Neurological Surgery faculty since 2001
Dr. Banerjee is a pediatrician with fellowship training in pediatric hematology and oncology. She is also an epidemiologist and has a special interest in pediatric palliative care. She currently works with Dr. Michael Prados in Pediatric Brain Tumor Consortium clinical trials. Dr. Banerjee's research at present involves the use of novel convection-enhanced delivery of novel drugs for treatment of high-grade glioma, and the role of signal transduction inhibitors with radiation for the treatment of brainstem glioma.
Education, Training, and Previous Positions
1987: BA, Stanford University
1990: MPH, Tulane School of Public Health
1992: MD, Tulane School of Medicine
1992-1996: Residency in Pediatrics, UCSF
1996-1999: Clinical Fellow, Pediatric Hematology and Oncology, UCSF
1999-2001: Assistant Clinical Professor of Pediatrics, UCSF
Selected Professional Memberships and Appointments
American Association for Cancer Research
American Society of Clinical Oncology
Children's Oncology Group
Pediatric Brain Tumor Consortium
Society for Neuro-Oncology
The American Society of Pediatric Hematology/Ooncology
Anuradha Banerjee MD, MPH
University of California, San Francisco
Department of Neurological Surgery
505 Parnassus Ave., M653
San Francisco, CA 94143-0106
Phone: (415) 353-3489 (academic)
(415) 353-2193 (clinical)
Selected Recent Publications
McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA. Radiation is an Important Component of Multimodality Therapy for Pediatric Non-Pineal Supratentorial Primitive Neuroectodermal Tumors [published online ahead of print May 15, 2008]. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2008.03.033
Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol 2008;10(3):341-7.
Pang J, Banerjee A, Tihan T. The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms. J Neurooncol 2008;87(1):97-102.
Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE. Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. J Clin Oncol 2007;25(21):3137-43.
Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 2007;9(2):145-60.
Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol 2006;8(2):166-74.
Etzell JE, Keet C, McDonald W, Banerjee A. Medulloblastoma simulating acute myeloid leukemia: case report with a review of "myeloid antigen" expression in nonhematopoietic tissues and tumors [Review]. J Pediatr Hematol Oncol 2006;28(11):703-10.
To contact the UCSF Department of Neurological Surgery with questions about medical matters, call 415-353-7500 or fax 415-353-2889.
For information about the UCSF Neurological Surgery Residency Program, call 415-353-3904 or fax 415-353-3907.
Copyright ©2003 UCSF Neurosurgery. All rights reserved.